人工智能在心血管疾病风险分层与个体化治疗中的应用进展
摘要
关键词
全文:
PDF镜像
|参考
[1]Artificial Intelligence in Cerebrovascular Disease Management: A Comprehensive Review of Risk Prediction, Diagnosis, Therapeutic Optimization, and Clinical Translation. Vascular Health and Risk Management, 2025, 21: 949-964.
[2]Jankauskas SS, Varzideh F, Kansakar U, Santulli G. Artificial Intelligence in Cardiovascular Medicine: A Giant Step in Personalized Medicine? Journal of Personalized Medicine, 2026, 16(4): 192.
[3]Alyacoub R. Artificial intelligence in heart failure - a comprehensive literature review. Cardiology Journal, 2025.
[4]A narrative review on the use of artificial intelligence in cardiovascular medicine. Cardiovascular Diagnosis and Therapy, 2026.
[5]Woodman RJ, et al. Clinical phenotypes of atrial fibrillation: A review of machine learning applications in personalized treatment. JRSM Cardiovascular Disease, 2025.
[6]Varzideh F, Mone P, Kansakar U, et al. Artificial Intelligence in Cardiovascular Medicine: Focus on Hypertension. Hypertension, 2026.
[7]Henna F, et al. Narrative Review on Explainable Artificial Intelligence for Multimodal Risk Stratification in Coronary Artery Disease. Cardiology in Review, 2025.
[8]Impact of Artificial Intelligence on Cardiovascular Disease Diagnosis, Risk Assessment, and Treatment: A Meta-Analysis of 45 Studies. Circulation, 2025, 152(Suppl_3).
[9]Greco A, et al. Personalized Treatment of Patients with Coronary Artery Disease: The Value and Limitations of Predictive Models. Journal of Cardiovascular Development and Disease, 2025.
[10]Tang YD, et al. Integrating multimodal intelligence in heart failure: AI-driven risk prediction, precision diagnosis, phenotyping, personalized treatment, and prognosis. Chinese Medical Journal, 2026.
(0 摘要 Views, 0 PDF Downloads)
Refbacks
- 当前没有refback。